title: Global invasive bacterial vaccine-preventable diseases surveillance--2008-2014.
abstract: Meningitis and pneumonia are leading causes of morbidity and mortality in children globally infected with Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis, and Haemophilus influenzae causing a large proportion of disease. Vaccines are available to prevent many of the common types of these infections. S. pneumoniae was estimated to have caused 11% of deaths in children aged <5 years globally in the pre-pneumococcal conjugate vaccine (PCV) era. Since 2007, the World Health Organization (WHO) has recommended inclusion of PCV in childhood immunization programs worldwide, especially in countries with high child mortality. As of November 26, 2014, a total of 112 (58%) of all 194 WHO member states and 44 (58%) of the 76 member states ever eligible for support from Gavi, the Vaccine Alliance (Gavi), have introduced PCV. Invasive pneumococcal disease (IPD) surveillance that includes data on serotypes, along with meningitis and pneumonia syndromic surveillance, provides important data to guide decisions to introduce PCV and monitor its impact.
authors.forename: Jillian
authors.initials: J
authors.lastname: Murray
authors.forename: Mary
authors.initials: M
authors.lastname: Agócs
authors.forename: Fatima
authors.initials: F
authors.lastname: Serhan
authors.forename: Simarjit
authors.initials: S
authors.lastname: Singh
authors.forename: Maria
authors.initials: M
authors.lastname: Deloria-Knoll
authors.forename: Katherine
authors.initials: K
authors.lastname: O'Brien
authors.forename: Jason M
authors.initials: JM
authors.lastname: Mwenda
authors.forename: Richard
authors.initials: R
authors.lastname: Mihigo
authors.forename: Lucia
authors.initials: L
authors.lastname: Oliveira
authors.forename: Nadia
authors.initials: N
authors.lastname: Teleb
authors.forename: Hinda
authors.initials: H
authors.lastname: Ahmed
authors.forename: Annemarie
authors.initials: A
authors.lastname: Wasley
authors.forename: Dovile
authors.initials: D
authors.lastname: Videbaek
authors.forename: Pushpa
authors.initials: P
authors.lastname: Wijesinghe
authors.forename: Arun Bhadra
authors.initials: AB
authors.lastname: Thapa
authors.forename: Kimberly
authors.initials: K
authors.lastname: Fox
authors.forename: Fem Julia
authors.initials: FJ
authors.lastname: Paladin
authors.forename: Rana
authors.initials: R
authors.lastname: Hajjeh
authors.forename: Stephanie
authors.initials: S
authors.lastname: Schwartz
authors.forename: Chris
authors.initials: C
authors.lastname: Van Beneden
authors.forename: Terri
authors.initials: T
authors.lastname: Hyde
authors.forename: Claire
authors.initials: C
authors.lastname: Broome
authors.forename: Thomas
authors.initials: T
authors.lastname: Cherian
mesh_terms: D002675:Child, Preschool; D014943:Global Health / Q000706:statistics & numerical data*; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration; D007223:Infant; D011008:Pneumococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D011159:Population Surveillance; D018074:Vaccines, Conjugate / Q000008:administration & dosage; D014944:World Health Organization
chemical_list: D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate